COX4I1 and Huntington disease: In particular, using an innovative high-throughput technology, we discovered that several biological elements involved in the oxidative phosphorylation system and two key constituents of the mitochondrial complex IV (COXI and COXIV) were deregulated in CKD/HD patients compared to healthy controls.